On June 1, 2024, Baillie Gifford (Trades, Portfolio), a prominent investment management firm, executed a significant transaction involving the shares of Ginkgo Bioworks Holdings Inc (NYSE:DNA). Baillie Gifford (Trades, Portfolio), established over a century ago, is renowned for its commitment to long-term, bottom-up investment approaches, focusing on fundamental analysis and proprietary research.
On June 1, 2024, Baillie Gifford (Trades, Portfolio) executed a significant transaction involving the sale of 590,921 shares of Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), marking a notable reduction in their investment. The transaction was carried out at a price of $148.43 per share, impacting Baillie Gifford (Trades, Portfolio)'s portfolio by -0.07%.
Joan Fair, a 75-year-old in Hamilton, Ont., wasn't aware she had any heart rate issues until she was alerted by her watch.